Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
JAMA Ophthalmology|June 8, 2013
Visual impairment, uncorrected refractive error, and objectively measured balance in the United StatesJeffrey R Willis, Susan E Vitale, Yuri Agrawal, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2012
Visual impairment, uncorrected refractive error, and accelerometer-defined physical activity in the United StatesJeffrey R Willis, Joan L Jefferys, Susan Vitale, et al.
Ophthalmology|August 16, 2012
Visual field loss and accelerometer-measured physical activity in the United StatesSuzanne W van Landingham, Jeffrey R Willis, Susan Vitale, et al.
Translational Vision Science & Technology|September 25, 2020
Development of Deep Learning Models to Predict Best-Corrected Visual Acuity from Optical Coherence TomographyMichael G Kawczynski, Thomas Bengtsson, Jian Dai, et al.
Ophthalmic Epidemiology|June 30, 2018
Self-reported healthcare utilization by adults with diabetic retinopathy in the United StatesJeffrey R Willis, Quan V Doan, Michelle Gleeson, et al.
JAMA Ophthalmology|July 28, 2017
Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United StatesJeffrey R Willis, Quan V Doan, Michelle Gleeson, et al.
Ophthalmology|June 26, 2016
The Prevalence of Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS(®) Data Registry and NHANESJeffrey R Willis, Susan Vitale, Lawrence Morse, et al.
Investigative Ophthalmology & Visual Science|March 2, 2019
Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus PhotographsFilippo Arcadu, Fethallah Benmansour, Andreas Maunz, et al.
Ophthalmology. Retina|May 11, 2025
Outcomes by Faricimab Treatment Interval at Week 48 of TENAYA-LUCERNE Phase 3 Trials in Neovascular Age-Related Macular DegenerationNikolas J S London, Chui Ming Gemmy Cheung, Stephan Michels, et al.
Ophthalmology|December 1, 2024
Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular DegenerationChui Ming Gemmy Cheung, Jennifer I Lim, Siegfried Priglinger, et al.
Pageof 4